semaglutide fda - Search News

Semaglutide shortage ends

Hosted on MSN · 1d

Semaglutide shortage ends as FDA sets deadline for compounders

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed – for now.

The Hill on MSN · 21h

Drug compounders sue over weight loss drugs’ removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug

FiercePharma · 1d

Compounders sue FDA again over declaring end of shortage for Novo's semaglutide

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. | Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight.

4don MSN

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

Hosted on MSN2d

What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle

Compounding pharmacy and IBD 50 newcomer Hims & Hers Health is expected late Monday to report bullish earnings and sales ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results